HLVX - HilleVax - Stock Price & Catalysts • BiopharmIQ

Enterprise Value

463.4M

Cash

260.5M

Avg Qtr Burn

-16.81M

Short % of Float

3.40%

Insider Ownership

11.52%

Institutional Own.

72.45%

Qtr Updated

03/31/23

Drug Pipeline

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.

Drug & Indication	Stage & Event	Catalyst Date
HIL-214 Details Norovirus	Phase 2b Data readout	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.